Gene Alterations of Ovarian Cancer Cells Expressing Estrogen Receptors by Estrogen and Bisphenol A Using Microarray Analysis.
- Author:
Kyung A HWANG
1
;
Se Hyung PARK
;
Bo Rim YI
;
Kyung Chul CHOI
Author Information
- Publication Type:In Vitro ; Original Article
- Keywords: Endocrine disrupting chemicals; estrogen; bisphenol; ovarian cancer
- MeSH: Anti-Mullerian Hormone; Apoptosis; Benzhydryl Compounds; Cell Cycle; Cyclin D1; Cyclin-Dependent Kinase 4; Endocrine Disruptors; Estrogens; Genes, ras; Humans; Insulin-Like Growth Factor Binding Protein 4; Microarray Analysis; Ovarian Neoplasms; Phenols; Receptors, Estrogen; RNA, Messenger; Signal Transduction
- From:Laboratory Animal Research 2011;27(2):99-107
- CountryRepublic of Korea
- Language:English
- Abstract: Since endocrine disrupting chemicals (EDCs) may interfere with the endocrine system(s) of our body and have an estrogenicity, we evaluated the effect(s) of bisphenol A (BPA) on the transcriptional levels of altered genes in estrogen receptor (ER)-positive BG-1 ovarian cancer cells by microarray and real-time polymerase-chain reaction. In this study, treatment with 17beta-estradiol (E2) or BPA increased mRNA levels of E2-responsive genes related to apoptosis, cancer and cell cycle, signal transduction and nucleic acid binding etc. In parallel with their microarray data, the mRNA levels of some altered genes including RAB31_MEMBER RAS ONCOGENE FAMILY (U59877), CYCLIN D1 (X59798), CYCLIN-DEPENDENT KINASE 4 (U37022), IGF-BINDING PROTEIN 4 (U20982), and ANTI-MULLERIAN HORMONE (NM_000479) were significantly induced by E2 or BPA in this cell model. These results indicate that BPA in parallel with E2 induced the transcriptional levels of E2-responsive genes in an estrogen receptor (ER)-positive BG-1 cells. In conclusion, these microarray and real-time polymerase-chain reaction results indicate that BPA, a potential weak estrogen, may have estrogenic effect by regulating E2-responsive genes in ER-positive BG-1 cells and BG-1 cells would be the best in vitro model to detect these estrogenic EDCs.
